Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Real-World, observational, retrospective cohort study evaluating effects and safety of Pirfenidone in Idiopathic Pulmonary Fibrosis patients.

Next Previous
Trial Profile

Real-World, observational, retrospective cohort study evaluating effects and safety of Pirfenidone in Idiopathic Pulmonary Fibrosis patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Nov 2018

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms IRENE

    • Most Recent Events

    • 30 Nov 2018 New trial record
    • 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top